The CAP1/Prss8 catalytic triad is not involved in PAR2 activation and protease nexin-1 (PN-1) inhibition.
Giovanna Crisante, Laura Battista, Justyna Iwaszkiewicz, Valeria Nesca, Anne-Marie Mérillat, Chloé Sergi, Vincent Zoete, Simona Frateschi, Edith Hummler
Index: FASEB J. 28(11) , 4792-805, (2014)
Full Text: HTML
Abstract
Serine proteases, serine protease inhibitors, and protease-activated receptors (PARs) are responsible for several human skin disorders characterized by impaired epidermal permeability barrier function, desquamation, and inflammation. In this study, we addressed the consequences of a catalytically dead serine protease on epidermal homeostasis, the activation of PAR2 and the inhibition by the serine protease inhibitor nexin-1. The catalytically inactive serine protease CAP1/Prss8, when ectopically expressed in the mouse, retained the ability to induce skin disorders as well as its catalytically active counterpart (75%, n=81). Moreover, this phenotype was completely normalized in a PAR2-null background, indicating that the effects mediated by the catalytically inactive CAP1/Prss8 depend on PAR2 (95%, n=131). Finally, nexin-1 displayed analogous inhibitory capacity on both wild-type and inactive mutant CAP1/Prss8 in vitro and in vivo (64% n=151 vs. 89% n=109, respectively), indicating that the catalytic site of CAP1/Prss8 is dispensable for nexin-1 inhibition. Our results demonstrate a novel inhibitory interaction between CAP1/Prss8 and nexin-1, opening the search for specific CAP1/Prss8 antagonists that are independent of its catalytic activity.© FASEB.
Related Compounds
Related Articles:
2014-08-01
[Mol. Plant 7(8) , 1365-83, (2014)]
2014-06-02
[J. Exp. Med. 211(6) , 1079-91, (2014)]
2012-07-01
[Int. J. Obes. 38(12) , 1538-44, (2014)]
2014-01-01
[PLoS Biol. 12(1) , e1001758, (2014)]
Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium.
2014-12-11
[Oncogene 33(50) , 5688-96, (2014)]